Participants 57 142 4
patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT.
Participants 309 354 3
patients with poor left-ventricular function.
Participants 1280 1364 6
EMIAT enrolled 1486 patients (743 in the amiodarone group, 743 in the placebo group)
